MKI67 and neoplasm: Figure 7G–I clearly revealed that the MC@Lip + US + NIR group showed no noticeable metastatic tumors in the lungs, confirming that the MC@Lip + US + NIR treatment strategy substantially exhibited a robust performance against lung metastasis. Histological analysis of these tumors revealed that the apparent tumor destruction, the least Ki-67-stained cells, and most TUNEL-positive cells appeared in the tumors received with MC@Lip + US + NIR (Figure S11, in the Supporting Information).